Testosterone Cypionate Injection — Class II drug recall D-1176-2022
Terminated recall by SUN PHARMACEUTICAL INDUSTRIES INC, reported 2022-07-13, distributed nationwide. CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.
| Recall number | D-1176-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ, United States |
| Recall initiated | 2022-06-03 |
| Classified | 2022-07-07 |
| Reported by FDA | 2022-07-13 |
| Terminated | 2023-05-25 |
| Distributed | Nationwide (US) |
| Quantity | 27 vials |
| Reason classes | cgmp |
| NDC | 62756-0015, 62756-0015-40, 62756-0016, 62756-0016-40, 62756-0017, 62756-0017-40 |
| Lot numbers | JKX3267A, JKX3686A, JKX4700A, JKX5727A |
| Expiration dates | 2022-08, 2022-10, 2022-11 |
Product
Testosterone Cypionate Injection, USP, 200mg/ml, Rx Only, One Single-dose vial, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.
Reason for recall
CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1176-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.